These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Updated UK Recommendations for HER2 assessment in breast cancer. Rakha EA; Pinder SE; Bartlett JM; Ibrahim M; Starczynski J; Carder PJ; Provenzano E; Hanby A; Hales S; Lee AH; Ellis IO; J Clin Pathol; 2015 Feb; 68(2):93-9. PubMed ID: 25488926 [TBL] [Abstract][Full Text] [Related]
4. European consensus conference for external quality assessment in molecular pathology. van Krieken JH; Siebers AG; Normanno N; Ann Oncol; 2013 Aug; 24(8):1958-63. PubMed ID: 23613479 [TBL] [Abstract][Full Text] [Related]
5. European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects. Keppens C; Dufraing K; van Krieken HJ; Siebers AG; Kafatos G; Lowe K; Demonty G; Dequeker EMC Virchows Arch; 2019 Jul; 475(1):25-37. PubMed ID: 30719547 [TBL] [Abstract][Full Text] [Related]
6. Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon? Keppens C; Tack V; Dufraing K; Rouleau E; Ligtenberg MJL; Schuuring E; Dequeker EMC Hum Mutat; 2020 Jan; 41(1):7-16. PubMed ID: 31553104 [TBL] [Abstract][Full Text] [Related]
7. EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy. Thunnissen E; Bovée JV; Bruinsma H; van den Brule AJ; Dinjens W; Heideman DA; Meulemans E; Nederlof P; van Noesel C; Prinsen CF; Scheidel K; van de Ven PM; de Weger R; Schuuring E; Ligtenberg M J Clin Pathol; 2011 Oct; 64(10):884-92. PubMed ID: 21947301 [TBL] [Abstract][Full Text] [Related]
8. Results of the UK NEQAS for Molecular Genetics reference sample analysis. Richman SD; Fairley J; Hall JA; Nataraj N; Bhide M; Lau A; Norman KL; Deans ZC J Clin Pathol; 2018 Nov; 71(11):989-994. PubMed ID: 30030291 [TBL] [Abstract][Full Text] [Related]
9. Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing. Jurmeister P; Vollbrecht C; Jöhrens K; Aust D; Behnke A; Stenzinger A; Penzel R; Endris V; Schirmacher P; Fisseler-Eckhoff A; Neumann J; Kirchner T; Büttner R; Merkelbach-Bruse S; Kreipe H; Jonigk D; Jochum W; Rodriguez R; Dietel M; Horst D; Hummel M; von Laffert M Virchows Arch; 2021 Aug; 479(2):247-255. PubMed ID: 34173019 [TBL] [Abstract][Full Text] [Related]
10. Guideline on the requirements of external quality assessment programs in molecular pathology. van Krieken JH; Normanno N; Blackhall F; Boone E; Botti G; Carneiro F; Celik I; Ciardiello F; Cree IA; Deans ZC; Edsjö A; Groenen PJ; Kamarainen O; Kreipe HH; Ligtenberg MJ; Marchetti A; Murray S; Opdam FJ; Patterson SD; Patton S; Pinto C; Rouleau E; Schuuring E; Sterck S; Taron M; Tejpar S; Timens W; Thunnissen E; van de Ven PM; Siebers AG; Dequeker E Virchows Arch; 2013 Jan; 462(1):27-37. PubMed ID: 23250354 [TBL] [Abstract][Full Text] [Related]
11. Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics. Kalman LV; Lubin IM; Barker S; du Sart D; Elles R; Grody WW; Pazzagli M; Richards S; Schrijver I; Zehnbauer B Arch Pathol Lab Med; 2013 Jul; 137(7):983-8. PubMed ID: 23808472 [TBL] [Abstract][Full Text] [Related]
12. Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories. Tack V; Schuuring E; Keppens C; Hart N'; Pauwels P; van Krieken H; Dequeker EMC Br J Cancer; 2018 Aug; 119(5):605-614. PubMed ID: 30140047 [TBL] [Abstract][Full Text] [Related]
14. PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation. Keppens C; Dequeker EM; Pauwels P; Ryska A; 't Hart N; von der Thüsen JH Virchows Arch; 2021 May; 478(5):827-839. PubMed ID: 33275169 [TBL] [Abstract][Full Text] [Related]
15. External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme. Esposito Abate R; Cheetham MH; Fairley JA; Pasquale R; Sacco A; Nicola W; Deans ZC; Patton SJ; Normanno N Virchows Arch; 2023 Feb; 482(2):347-355. PubMed ID: 36355212 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect. Keppens C; Boone E; Gameiro P; Tack V; Moreau E; Hodges E; Evans P; Brüggemann M; Carter I; Lenze D; Sarasquete ME; Möbs M; Liu H; Dequeker EMC; Groenen PJTA Virchows Arch; 2021 Aug; 479(2):365-376. PubMed ID: 33686511 [TBL] [Abstract][Full Text] [Related]
17. An overview of the European Organization for External Quality Assurance Providers in Laboratory Medicine (EQALM). Stavelin A; Albe X; Meijer P; Sarkany E; MacKenzie F Biochem Med (Zagreb); 2017 Feb; 27(1):30-36. PubMed ID: 28392724 [TBL] [Abstract][Full Text] [Related]
18. External quality assessment (EQA) and alternative assessment procedures (AAPs) in molecular diagnostics: findings of an international survey. Payne DA; Russomando G; Linder MW; Baluchova K; Ashavaid T; Steimer W; Ahmad-Nejad P; Clin Chem Lab Med; 2020 May; 59(2):301-306. PubMed ID: 32383687 [TBL] [Abstract][Full Text] [Related]
19. The updated 2018 American Society of Clinical Oncology/College of American Pathologists guideline on human epidermal growth factor receptor 2 interpretation in breast cancer: comparison with previous guidelines and clinical significance of the proposed in situ hybridization groups. Woo JW; Lee K; Chung YR; Jang MH; Ahn S; Park SY Hum Pathol; 2020 Apr; 98():10-21. PubMed ID: 32027910 [TBL] [Abstract][Full Text] [Related]
20. Schemes and Performance Evaluation Criteria of Korean Association of External Quality Assessment (KEQAS) for Improving Laboratory Testing. Kim S; Lee K; Park HD; Lee YW; Chun S; Min WK Ann Lab Med; 2021 Mar; 41(2):230-239. PubMed ID: 33063686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]